M. Lires-Deán

582 total citations
8 papers, 488 citations indexed

About

M. Lires-Deán is a scholar working on Pharmacology, Rheumatology and Molecular Biology. According to data from OpenAlex, M. Lires-Deán has authored 8 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Rheumatology and 3 papers in Molecular Biology. Recurrent topics in M. Lires-Deán's work include Inflammatory mediators and NSAID effects (4 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and NF-κB Signaling Pathways (2 papers). M. Lires-Deán is often cited by papers focused on Inflammatory mediators and NSAID effects (4 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and NF-κB Signaling Pathways (2 papers). M. Lires-Deán collaborates with scholars based in Spain, Australia and Denmark. M. Lires-Deán's co-authors include Berta Cillero‐Pastor, M.J. López-Armada, B. Caramés, Francisco J. Blanco, F. Galdo, Cristina Ruíz‐Romero, Joaquı́n Arenas, Miguel A. Martı́n, Isaac Fuentes‐Boquete and Carlos Vaamonde‐García and has published in prestigious journals such as Osteoarthritis and Cartilage, Reumatología Clínica and Arthritis & Rheumatism.

In The Last Decade

M. Lires-Deán

8 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Lires-Deán Spain 6 302 192 120 91 63 8 488
Heba Ismail United Kingdom 12 212 0.7× 261 1.4× 99 0.8× 83 0.9× 42 0.7× 24 519
B.C. Søndergaard Denmark 10 420 1.4× 174 0.9× 210 1.8× 132 1.5× 53 0.8× 17 651
Sabrina Priam France 7 175 0.6× 190 1.0× 85 0.7× 65 0.7× 29 0.5× 13 458
C. Cherifi France 7 296 1.0× 183 1.0× 124 1.0× 71 0.8× 41 0.7× 12 445
Johanne Martel‐Pelletier Canada 11 381 1.3× 257 1.3× 245 2.0× 67 0.7× 49 0.8× 12 614
Sunli Hu China 13 161 0.5× 291 1.5× 100 0.8× 87 1.0× 74 1.2× 15 604
Helal Endisha Canada 8 360 1.2× 311 1.6× 104 0.9× 213 2.3× 40 0.6× 13 575
Wenfeng Xiao China 13 344 1.1× 222 1.2× 109 0.9× 91 1.0× 29 0.5× 25 622
V.B. Kraus United States 11 275 0.9× 110 0.6× 101 0.8× 67 0.7× 23 0.4× 51 447
Weiyuan Gong China 7 456 1.5× 297 1.5× 158 1.3× 121 1.3× 53 0.8× 10 745

Countries citing papers authored by M. Lires-Deán

Since Specialization
Citations

This map shows the geographic impact of M. Lires-Deán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lires-Deán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lires-Deán more than expected).

Fields of papers citing papers by M. Lires-Deán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Lires-Deán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lires-Deán. The network helps show where M. Lires-Deán may publish in the future.

Co-authorship network of co-authors of M. Lires-Deán

This figure shows the co-authorship network connecting the top 25 collaborators of M. Lires-Deán. A scholar is included among the top collaborators of M. Lires-Deán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Lires-Deán. M. Lires-Deán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lires-Deán, M., B. Caramés, Berta Cillero‐Pastor, et al.. (2008). Anti-apoptotic effect of transforming growth factor-β1 on human articular chondrocytes: role of protein phosphatase 2A. Osteoarthritis and Cartilage. 16(11). 1370–1378. 24 indexed citations
2.
Cillero‐Pastor, Berta, B. Caramés, M. Lires-Deán, et al.. (2008). Mitochondrial dysfunction activates cyclooxygenase 2 expression in cultured normal human chondrocytes. Arthritis & Rheumatism. 58(8). 2409–2419. 87 indexed citations
3.
López-Armada, M.J., et al.. (2007). Evidencia de mecanismos inflamatorios en la osteoartritis. Reumatología Clínica. 3. S23–S27. 6 indexed citations
4.
Caramés, B., M.J. López-Armada, Berta Cillero‐Pastor, et al.. (2007). Differential effects of tumor necrosis factor-α and interleukin-1β on cell death in human articular chondrocytes. Osteoarthritis and Cartilage. 16(6). 715–722. 72 indexed citations
5.
Caramés, B., M.J. López-Armada, M. Lires-Deán, et al.. (2007). 207 TUMOR NECROSIS FACTOR α BUT NOT INTERLEUKIN 1 β POTENCIATE CELL DEATH INDUCED BY Ro 31-8220, A PROTEIN KINASE INHIBITOR, IN NORMAL HUMAN ARTICULAR CHONDROCYTES. Osteoarthritis and Cartilage. 15. C120–C121. 1 indexed citations
7.
López-Armada, M.J., B. Caramés, Miguel A. Martı́n, et al.. (2006). Mitochondrial activity is modulated by TNFα and IL-1β in normal human chondrocyte cells. Osteoarthritis and Cartilage. 14(10). 1011–1022. 128 indexed citations
8.
López-Armada, M.J., B. Caramés, M. Lires-Deán, et al.. (2006). Cytokines, tumor necrosis factor-α and interleukin-1β, differentially regulate apoptosis in osteoarthritis cultured human chondrocytes. Osteoarthritis and Cartilage. 14(7). 660–669. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026